Oxford vaccine spat could lead to divergence in Covid strategies
Analysis: different nations could go different ways on who gets vaccine once it is available
Millions of people in the UK who have received a first dose of the Oxford/AstraZeneca vaccine against Covid may be dismayed by the decision of German scientists not to recommend its use in the over-65s. Most of them are in that age group.
The comments from Stiko, the standing committee on vaccination that advises the German government, may well pre-empt a similar announcement by Europe’s medical regulator. Europe is expected on Friday to authorise use of the Oxford vaccine, and Emer Cooke, the head of the European Medicines Agency, this week trailed the possibility that the agency could say the vaccine should be used only for certain age groups.
Read the original article at The Guardian